Hironobu Hamada Selected Research

Hironobu Hamada Research Topics

Disease

25	Neoplasms (Cancer) 07/2022 - 11/2004
18	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2022 - 02/2002
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 08/2007
15	Lung Neoplasms (Lung Cancer) 07/2022 - 10/2008
9	Adenocarcinoma of Lung 01/2022 - 06/2007
9	Malignant Mesothelioma 01/2018 - 03/2006
8	Fibrosis (Cirrhosis) 01/2021 - 01/2017
8	Idiopathic Pulmonary Fibrosis 01/2021 - 02/2002
7	Lung Injury 01/2022 - 12/2002
6	Asthma (Bronchial Asthma) 12/2022 - 03/2006
6	Pneumonia (Pneumonitis) 10/2022 - 11/2004
6	Bronchiectasis 02/2021 - 04/2013
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2016
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2021 - 02/2002
5	Inflammation (Inflammations) 01/2021 - 01/2017
5	Neoplasm Metastasis (Metastasis) 09/2020 - 02/2002
4	Disease Progression 07/2022 - 06/2010
4	Acute Lung Injury 01/2022 - 01/2013
3	Respiratory Insufficiency (Respiratory Failure) 02/2022 - 01/2007
3	Emphysema 04/2021 - 01/2016
3	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2019 - 12/2002
3	Pleural Effusion (Pleural Effusions) 08/2012 - 03/2006
2	Venous Thromboembolism 02/2021 - 03/2019
2	Disseminated Intravascular Coagulation 02/2021 - 01/2014
2	Dyspnea (Shortness of Breath) 02/2021 - 01/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 12/2018
2	Intracranial Embolism 01/2020 - 03/2019
2	Adenocarcinoma 01/2019 - 06/2007
2	Sepsis (Septicemia) 01/2018 - 01/2013
2	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 06/2017 - 02/2002
2	Bacterial Pneumonia 01/2016 - 02/2002
2	Mesothelioma 02/2013 - 04/2010
1	Exophthalmos (Proptosis) 12/2022
1	Immunoglobulin G4-Related Disease 12/2022
1	Meningoencephalitis 10/2022
1	Chickenpox 10/2022
1	Rheumatoid Arthritis 10/2022
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 04/2022

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2002
8	LigandsIBA 07/2022 - 01/2016
6	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 03/2006
6	Pharmaceutical PreparationsIBA 02/2021 - 11/2004
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 06/2008
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
4	CytokinesIBA 01/2021 - 01/2017
4	AntibodiesIBA 11/2019 - 06/2007
4	Mucin-1 (CA 15-3 Antigen)IBA 01/2019 - 03/2006
4	Plasminogen Activator Inhibitor 1IBA 01/2019 - 01/2016
4	Plasminogen Activators (Plasminogen Activator)IBA 01/2019 - 01/2016
4	AsbestosIBA 02/2013 - 03/2006
3	Immunoglobulin G (IgG)IBA 12/2022 - 01/2012
3	SteroidsIBA 12/2022 - 08/2003
3	Receptor for Advanced Glycation End ProductsIBA 01/2022 - 01/2017
3	HMGB1 Protein (HMG1)IBA 12/2021 - 01/2020
3	AntigensIBA 04/2021 - 01/2017
3	pembrolizumabIBA 03/2020 - 03/2019
3	Monoclonal AntibodiesIBA 01/2012 - 07/2004
2	Prednisolone (Predate)FDA LinkGeneric 12/2022 - 01/2018
2	Indicators and Reagents (Reagents)IBA 02/2021 - 01/2007
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2021
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2021 - 04/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2017
2	Bronchodilator Agents (Bronchodilators)IBA 01/2021 - 03/2006
2	Small Interfering RNA (siRNA)IBA 01/2021 - 09/2018
2	Immune Checkpoint InhibitorsIBA 11/2020 - 09/2019
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019 - 12/2018
2	suplatast tosilateIBA 01/2019 - 01/2017
2	ChemokinesIBA 01/2019 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2018 - 03/2006
2	Docetaxel (Taxotere)FDA Link 09/2018 - 08/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 02/2013
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2016 - 02/2002
2	SK-216IBA 01/2016 - 01/2016
2	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2014 - 01/2013
2	SugarsIBA 01/2012 - 07/2004
2	Tyrosine Kinase InhibitorsIBA 07/2011 - 06/2008
2	Tumor Biomarkers (Tumor Markers)IBA 10/2008 - 06/2008
2	Glycoproteins (Glycoprotein)IBA 06/2007 - 03/2006
1	GlucocorticoidsIBA 12/2022
1	dupilumabIBA 12/2022
1	InterleukinsIBA 12/2022
1	Interleukin-13IBA 12/2022
1	Methotrexate (Mexate)FDA LinkGeneric 10/2022
1	iguratimodIBA 10/2022
1	Valacyclovir (Valtrex)FDA LinkGeneric 10/2022
1	tepotinibIBA 06/2022
1	capmatinibIBA 06/2022
1	ParaffinIBA 04/2022
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 04/2022

Therapy/Procedure

21	Drug Therapy (Chemotherapy) 07/2022 - 02/2002
9	Therapeutics 01/2021 - 01/2004
6	Radiotherapy 01/2021 - 02/2002
5	Traction 02/2021 - 01/2018
3	Chemoradiotherapy 09/2021 - 10/2017
2	Oral Administration 10/2022 - 06/2017
2	Catheters 01/2020 - 01/2018
2	Aftercare (After-Treatment) 06/2011 - 02/2005
1	Operative Surgical Procedures 07/2022
1	General Anesthesia 02/2022